Cardinal Health delivered a strong start to fiscal 2025, marked by significant growth in the Pharma segment and improved guidance for the year. However, challenges in the GMPD segment and potential cost impacts from tariffs pose risks that could affect future performance.

Company Guidance

During the Q1 2025 earnings call, Cardinal Health provided updated guidance, raising their EPS expectations to a range of $7.75 to $7.90 and adjusting the adjusted free cash flow outlook to $1 billion to $1.5 billion. The company reported a 12% increase in operating earnings and a 9% rise in EPS, driven by a 16% segment profit growth in Pharma and Specialty Solutions. Overall revenue decreased by 4% to $52 billion due to a large customer transition, but adjusted revenue increased by 15% year-over-year. GLP-1 sales contributed 5 percentage points to Pharma revenue growth, and COVID-19 vaccine distribution had a slight positive impact on the quarter's earnings. Total company gross margin rose by 9%, supported by positive trends in both brand and generics. Despite unexpected health and welfare costs impacting GMPD results, the company remains focused on its GMPD improvement plan, adjusting its segment profit outlook to $140 million to $175 million for fiscal '25. The Nuclear, at-Home, and OptiFreight businesses showed strong demand, contributing to an 8% segment profit growth in other categories.

Strong Start to Fiscal 2025

Cardinal Health reported a strong start to fiscal 2025, with a 12% increase in operating earnings and a 9% increase in EPS, driven by the Pharma segment.

Pharma Segment Performance

The Pharma segment saw a 16% profit increase, driven by strong demand across brand, specialty, consumer health, and generics. The segment's revenue, excluding a large customer transition, increased by 16%.

Increased Guidance

EPS guidance for fiscal 2025 has been raised to $7.75-$7.90, and adjusted free cash flow outlook increased to $1 billion-$1.5 billion.

Revenue from New Customers

Cardinal Health successfully onboarded new customers, contributing over $10 billion in incremental revenue for the year.

OptiFreight Logistics Growth

OptiFreight Logistics reported strong demand, contributing to an 8% increase in segment profit for businesses reported in 'Other'.

---

Cardinal Health (CAH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

CAH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Jan 30, 2025	2025 (Q2)	1.76 / -	1.82	―	―	―
Nov 01, 2024	2025 (Q1)	1.62 / 1.88	1.73	8.67% (+0.15)
Aug 14, 2024	2024 (Q4)	1.73 / 1.84	1.55	18.71% (+0.29)
May 02, 2024	2024 (Q3)	1.95 / 2.08	1.74	19.54% (+0.34)
Feb 01, 2024	2024 (Q2)	1.60 / 1.82	1.32	37.88% (+0.50)
Nov 03, 2023	2024 (Q1)	1.40 / 1.73	1.2	44.17% (+0.53)
Aug 15, 2023	2023 (Q4)	1.49 / 1.55	1.05	47.62% (+0.50)
May 04, 2023	2023 (Q3)	1.49 / 1.74	1.45	20.00% (+0.29)
Feb 02, 2023	2023 (Q2)	1.14 / 1.32	1.27	3.94% (+0.05)
Nov 04, 2022	2023 (Q1)	0.94 / 1.20	1.29	-6.98% (-0.09)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

---

CAH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Nov 01, 2024	$108.52	$116.13	+7.01%
Aug 14, 2024	$102.11	$105.87	+3.68%
May 02, 2024	$101.18	$101.98	+0.79%
Feb 01, 2024	$107.65	$103.62	-3.74%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

---